Listed

Black Diamond Therapeutics, Inc.: Form 10-Q for the period ended Jun 30, 2020

Filed with the SEC on Aug 11, 2020 and accepted by EDGAR at Aug 11, 2020, 07:22 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2020-04-01 to 2020-06-30$10.2mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2020-01-01 to 2020-06-30$17.5mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2020-04-01 to 2020-06-30−$15.0mus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-01 to 2020-06-30−$27.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-04-01 to 2020-06-30$1.0kus-gaap:InterestExpense
Interest expense6 months2020-01-01 to 2020-06-30$1.0kus-gaap:InterestExpense
Net income3 months2020-04-01 to 2020-06-30−$14.6mus-gaap:NetIncomeLoss
Net income6 months2020-01-01 to 2020-06-30−$26.7mus-gaap:NetIncomeLoss
Operating cash flow6 months2020-01-01 to 2020-06-30−$24.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-01 to 2020-06-30$25.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-06-30$64.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-06-30$208.2mus-gaap:AssetsCurrent
Total assetsAt period end2020-06-30$349.4mus-gaap:Assets
Current liabilitiesAt period end2020-06-30$6.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-06-30$6.3mus-gaap:Liabilities
Shareholders' equityAt period end2020-06-30$343.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001701541-20-000024. Last ingested by Listed: Nov 10, 2026, 16:37 ET. Listed shows no prices and gives no investment advice.